Effect of 6-hydroxydopamine on hypothalamic norepinephrine and dopamine content, ultrastructure of the median eminence, and plasma corticosterone.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000818:Animals; D003345:Corticosterone / Q000097:blood*; D004298:Dopamine / Q000378:metabolism*; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D007030:Hypothalamo-Hypophyseal System / Q000648:ultrastructure*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008473:Median Eminence / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D008854:Microscopy, Electron; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D013154:Spleen / Q000378:metabolism; D013687:Telencephalon / Q000378:metabolism; D013997:Time Factors
D006892:Hydroxydopamines; D000324:Adrenocorticotropic Hormone; D004298:Dopamine; D003345:Corticosterone; D009638:Norepinephrine